Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 146,267 | 62,546 | 31,575 | 32,412 | 151,805 |
| Gross Profit | 146,267 | 62,546 | 31,575 | 32,412 | 151,805 |
| Operating Expenses | 98,102 | 104,680 | 115,405 | 105,321 | 110,252 |
| Operating Income | 48,165 | -42,134 | -83,830 | -72,909 | 41,553 |
| Interest Expense | 5,057 | 2,849 | 0 | 0 | 0 |
| Other Income | 4,568 | 3,189 | 1,673 | 863 | 2,813 |
| Pre-tax Income | 47,676 | -41,794 | -82,157 | -72,046 | 44,366 |
| Income Tax | N/A | 17 | N/A | N/A | N/A |
| Net Income Continuous | 47,676 | -41,811 | -85,942 | -72,046 | 44,366 |
| Minority Interests | -999 | -486 | N/A | N/A | N/A |
| Net Income | $48,675 | $-41,325 | $-85,511 | $-72,046 | $44,366 |
| EPS Basic Total Ops | 0.46 | -0.39 | -0.81 | -0.68 | 0.42 |
| EPS Basic Continuous Ops | 0.45 | -0.39 | -0.81 | -0.68 | 0.42 |
| EPS Diluted Total Ops | 0.45 | -0.39 | -0.80 | -0.68 | 0.41 |
| EPS Diluted Continuous Ops | 0.44 | -0.39 | -0.80 | -0.68 | 0.41 |
| EPS Diluted Before Non-Recurring Items | 0.45 | -0.39 | -0.81 | N/A | N/A |
| EBITDA(a) | $50,062 | $-38,755 | $-80,273 | $-68,631 | $44,756 |